1. Home
  2. Medical Research
  3. New York, NY
  4. Childrens Tumor Foundation

Childrens Tumor Foundation

Childrens Tumor Foundation is ranked #9 of 39 medical research organizations in New York, NY, with an America's Best Score of 76 out of 100, based on its 2024 Form 990.

  • New York, NY
  • Tax-exempt since 1984
  • EIN: 13-2298956
ctf.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
76OF 100 #9 of 39 in New York ranked medical research organizations How this score is calculated

Organization summary

Childrens Tumor Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H50Z). Contributions are tax-deductible.

697 3Rd Avenue 418, New York, NY 10017-4003

Among the 61 scored medical research organizations in New York, Childrens Tumor Foundation holds 16.9 months of operating reserves (peer median 13.5 months), runs a typical yearly surplus of 3.8% (peers: surplus of 3.4%), and has grown spending 9.6% a year (peers: grown spending 7.0% a year).

In fiscal year 2024 it reported $19,738,640 in revenue and $19,009,492 in expenses, with contributions making up 95.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

Our mission: Drive research, expand knowledge, and advance care for the nf community. Our vision: End nf.

Largest programs · fiscal year 2024

  • Research - the children's tumor foundation supports nf research through a range of funding mechanisms. Our investments in research are three-fold: 1) To attract talented investigators to nf research; 2) To support innovative research; and 3) To foster collaborative efforts to find treatments and cures for neurofibromatosis. The foundation has been at the forefront of key advances in nf research in… Read more

    Research - the children's tumor foundation supports nf research through a range of funding mechanisms. Our investments in research are three-fold: 1) To attract talented investigators to nf research; 2) To support innovative research; and 3) To foster collaborative efforts to find treatments and cures for neurofibromatosis. The foundation has been at the forefront of key advances in nf research including funding the laboratories that discovered the nf1 and nf2 genes, supporting groundbreaking clinical trials, and establishing the first nationwide nf clinic network and nf patient registry. The foundation sponsors an annual scientific conference which brings researchers together to discuss the latest scientific developments related to nf. Additonally, our porgrams are designed to integrate with and support larger federally funded projects through the congressionally directed medical research program (cdmrp) and nih.

    $11,061,408 spent · 69.5% of program spending
  • Public education and patient support - the children's tumor foundation engages in public education through its website, quarterly newsletters, media coverage, and its national programs. Through our nf endurance and nf walk programs, the foundation highlights nf heroes and their triumphant spirits. The foundation also sponsors benefit dinners and regional and local events to promote awareness. The… Read more

    Public education and patient support - the children's tumor foundation engages in public education through its website, quarterly newsletters, media coverage, and its national programs. Through our nf endurance and nf walk programs, the foundation highlights nf heroes and their triumphant spirits. The foundation also sponsors benefit dinners and regional and local events to promote awareness. The children's tumor foundation is dedicated to supporting patients with nf as well as their family members. Through the nf clinic network and the annual nf forum, the foundation brings researchers, providers, and families together to discuss developments in treatments. The foundation also sponsors the annual nf camp which brings nf teens together for one week to enjoy the support and fellowship of their peers. Regional symposia are also held throughout the year.

    $4,863,943 spent · 30.5% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 84¢ went to programs, 8¢ to management and 8¢ to fundraising.

  • Programs $15,925,351
  • Management $1,526,148
  • Fundraising $1,557,993

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score76 / 100
Rank in New York#9 of 39
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves16.9 mo; 10.1 mo in cash11.7 / 25
Financial balance (median margin)+3.8%12.8 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+9.6% / yr12.3 / 15
Track record42 years10 / 10
Debt load12.7% of assets9.5 / 10
Total76.3 → 76
Spending on programs
Not scored; America's Best needs 65%+
84%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves16.9 mo13.5 mo
Typical margin+3.8%+3.4%
Spending growth+9.6% / yr+7.0% / yr
Debt load12.7%13.5%

Peers: the 61 New York medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$19,738,640Fiscal year 20242022: $16,990,32520222023: $16,447,28920232024: $19,738,6402024
Expenses$19,009,492Fiscal year 20242022: $15,815,54820222023: $18,828,15220232024: $19,009,4922024
Total assets$30,677,831Fiscal year 20242022: $32,079,77420222023: $30,074,60320232024: $30,677,8312024
Total liabilities$3,908,305Fiscal year 20242022: $4,527,79220222023: $4,353,70320232024: $3,908,3052024
Fiscal year ending December 2024
Revenue$19,738,640
Expenses$19,009,492
Net income$729,148
Net assets$26,769,526

Notable sources of revenue

Percent of total revenue
Contributions$18,893,523
Program services$25,665
Investment income$853,571
Other (net)−$34,119

Assets / debt

Total assets$30,677,831
Total liabilities$3,908,305
Net assets$26,769,526

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$16,447,289
Expenses$18,828,152
Net income−$2,380,863
Net assets$25,720,900

Notable sources of revenue

Percent of total revenue
Contributions$15,690,910
Program services$5,020
Investment income$913,419
Other (net)−$162,060

Assets / debt

Total assets$30,074,603
Total liabilities$4,353,703
Net assets$25,720,900

Compensation

Officers and key employees$877,453
Share of expenses4.7%
Fiscal year ending December 2022
Revenue$16,990,325
Expenses$15,815,548
Net income$1,174,777
Net assets$27,551,982

Notable sources of revenue

Percent of total revenue
Contributions$15,521,908
Program services$1,169,034
Investment income$292,495
Other (net)$6,888

Assets / debt

Total assets$32,079,774
Total liabilities$4,527,792
Net assets$27,551,982

Compensation

Officers and key employees$616,398
Share of expenses3.9%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?